U.S. Stem Cell, Inc. (USRM)
0.0001
0.00 (0.00%)
USD |
OTCM |
Sep 08, 16:00
U.S. Stem Cell Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | -2.83K% |
| September 30, 2022 | -3.98K% |
| June 30, 2022 | -2.33K% |
| March 31, 2022 | -4.96K% |
| December 31, 2021 | -2.72K% |
| September 30, 2021 | -1.17K% |
| June 30, 2021 | -2.81K% |
| March 31, 2021 | -1.16K% |
| December 31, 2020 | -511.4% |
| September 30, 2020 | -1.79K% |
| June 30, 2020 | -1.43K% |
| March 31, 2020 | -1.00K% |
| December 31, 2019 | -219.2% |
| September 30, 2019 | -1.05K% |
| June 30, 2019 | -64.65% |
| March 31, 2019 | -51.44% |
| December 31, 2018 | -26.80% |
| September 30, 2018 | -22.00% |
| June 30, 2018 | -68.36% |
| March 31, 2018 | -8.13% |
| December 31, 2017 | 23.55% |
| September 30, 2017 | -61.85% |
| June 30, 2017 | -30.64% |
| March 31, 2017 | -214.0% |
| December 31, 2016 | 33.83% |
| Date | Value |
|---|---|
| September 30, 2016 | -230.3% |
| June 30, 2016 | -52.03% |
| March 31, 2016 | -51.10% |
| December 31, 2015 | -234.8% |
| September 30, 2015 | -21.77% |
| June 30, 2015 | |
| March 31, 2015 | -214.1% |
| December 31, 2014 | -204.5% |
| September 30, 2014 | -254.2% |
| June 30, 2014 | -90.82% |
| March 31, 2014 | |
| December 31, 2013 | -756.8% |
| September 30, 2013 | |
| June 30, 2013 | -3.73K% |
| March 31, 2013 | -12.35K% |
| December 31, 2012 | -8.67K% |
| September 30, 2012 | -26.94K% |
| June 30, 2012 | -28.16K% |
| March 31, 2012 | -2.34K% |
| December 31, 2011 | -9.29K% |
| September 30, 2011 | -45.01K% |
| June 30, 2011 | -37.76K% |
| March 31, 2011 | |
| December 31, 2010 | -26.19K% |
| September 30, 2010 | -13.74K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -22.65% |
| BioRestorative Therapies, Inc. | -9.29K% |
| Elite Health Systems, Inc. | -116.9% |
| Marijuana, Inc. | -- |
| CareDx, Inc. | 83.85% |